This inventor holds 1 USPTO granted patent. Top assignee: Universitat Heidelberg. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Markus Hecker in the Field of NFAT Binding Polynucleotides
Introduction
Markus Hecker is an accomplished inventor based in Heidelberg, Germany. He has made significant contributions to the field of molecular biology, particularly in the development of polynucleotides that target the Nuclear factor of activated T-cells (NFAT). His work has implications for treating and preventing various diseases.
Latest Patents
Hecker holds a patent for a polynucleotide that comprises an NFAT binding site sequence and its reverse complement, separated by a spacer sequence. This invention is designed for use in treating and/or preventing diseases related to NFAT. The patent also covers viral particles, compositions, and related uses, showcasing the potential applications of his work in therapeutic contexts.
Career Highlights
Markus Hecker is affiliated with Universitat Heidelberg, where he conducts his research and development activities. His innovative approach to polynucleotide design has positioned him as a notable figure in his field, contributing to advancements in medical science.
Collaborations
Hecker has collaborated with esteemed colleagues such as Andreas Wagner and Andreas Jungmann. These partnerships have likely enhanced the scope and impact of his research endeavors.
Conclusion
Markus Hecker's work on NFAT binding polynucleotides represents a significant advancement in the field of molecular biology. His contributions have the potential to lead to new therapeutic strategies for NFAT-mediated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile